Antipsychotic drugs and sudden cardiac death: A literature review of the challenges in the prediction, management, and future steps
Authors:
- Chuanjun ZhuoCZChuanjun Zhuo
Open Access
- 1 November 2019
- journal article
- review article
- Published by Elsevier in Psychiatry Research
- Vol. 281, 112598
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 61 references indexed in Scilit:
- Pimavanserin for the treatment of Parkinson's disease psychosisExpert Opinion on Pharmacotherapy, 2013
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysisThe Lancet, 2013
- The response to sulpiride in social anxiety disorder: D2 receptor functionJournal of Psychopharmacology, 2012
- Ziprasidone Hydrocloride: What Role in the Management of Schizophrenia?Journal of Central Nervous System Disease, 2011
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac DeathNew England Journal of Medicine, 2009
- Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarctionEuropean Heart Journal, 2005
- Inherited and Acquired Vulnerability to Ventricular Arrhythmias: Cardiac Na+and K+ChannelsPhysiological Reviews, 2005
- The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophreniaMolecular Psychiatry, 2002
- Pharmacokinetics of HaloperidolClinical Pharmacokinetics, 1999
- A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in FinlandActa Psychiatrica Scandinavica, 1991